Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 30, 2019 |
Apr. 30, 2018 |
| Cash flows from operating activities: |
|
|
| Net loss |
$ (45,722)
|
$ (270,687)
|
| Adjustments to reconcile net loss to net cash used in operating activities |
|
|
| Depreciation and amortization |
11,971
|
8,600
|
| Amortization of deferred contract acquisition and fulfillment costs |
14,260
|
9,246
|
| Amortization of debt discount and transaction costs |
6,454
|
0
|
| Amortization of operating lease right-of-use assets |
4,128
|
|
| Stock-based compensation expense |
42,271
|
269,794
|
| Deferred income taxes |
52
|
(6)
|
| Other |
(1,111)
|
2,225
|
| Changes in operating assets and liabilities |
|
|
| Accounts receivable |
57,414
|
19,622
|
| Contract assets |
(2,701)
|
2,546
|
| Prepaid expenses and other current assets |
(7,107)
|
(6,519)
|
| Deferred contract acquisition and fulfillment costs |
(20,487)
|
(12,326)
|
| Other assets |
541
|
440
|
| Accounts payable |
282
|
(7,218)
|
| Accrued expenses |
6,442
|
3,302
|
| Accrued compensation |
(19,869)
|
(16,947)
|
| Contract liabilities |
4,274
|
12,611
|
| Operating lease liabilities |
(3,705)
|
|
| Other liabilities |
(1,732)
|
309
|
| Net cash provided by operating activities |
45,655
|
14,992
|
| Cash flows from investing activities: |
|
|
| Purchases of marketable securities |
(375,211)
|
0
|
| Maturities of marketable securities |
92,457
|
0
|
| Purchases of strategic investments |
(15,500)
|
0
|
| Purchases of property and equipment |
(15,237)
|
(6,184)
|
| Net cash used in investing activities |
(313,491)
|
(6,184)
|
| Cash flows from financing activities: |
|
|
| Payment of tax withholding obligation on RSU settlement |
(56,137)
|
0
|
| Proceeds from exercise of stock options |
32,254
|
7,815
|
| Proceeds from employee stock purchase plan |
10,563
|
0
|
| Payment of deferred offering costs |
0
|
(2,194)
|
| Net cash provided by (used in) financing activities |
(13,320)
|
5,621
|
| Effect of foreign exchange on cash, cash equivalents and restricted cash |
(379)
|
(2,069)
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
(281,535)
|
12,360
|
| Cash, cash equivalents and restricted cash at beginning of period |
518,178
|
257,436
|
| Cash, cash equivalents and restricted cash at end of period |
236,643
|
269,796
|
| Supplemental disclosure: |
|
|
| Cash paid for interest |
1,414
|
144
|
| Cash paid for operating lease liabilities |
4,729
|
|
| Cash paid for taxes |
131
|
1,516
|
| Non-cash investing and financing activities: |
|
|
| Property and equipment in accounts payable and other accrued liabilities |
3,791
|
3,238
|
| Preferred stock accretion |
0
|
353
|
| Deferred offering costs accrued and unpaid |
0
|
$ 1,173
|
| Operating lease right-of-use assets exchanged for lease obligations |
53,653
|
|
| Derecognition of build-to-suit lease |
$ 2,479
|
|